Background Cancer‐related fatigue is recognised as an important symptom associated with
cancer and its treatment. A number of studies have investigated the effects of physical …

Background Anaemia associated with cancer and cancer therapy is an important clinical
factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant …

Background Pazopanib and sunitinib provided a progression-free survival benefit, as
compared with placebo or interferon, in previous phase 3 studies involving patients with …

Anaemia and iron deficiency (ID) are frequent complications in patients with solid tumours or
haematological malignancies, particularly in patients treated with chemotherapeutic agents …

Importance In one-third of older men with anemia, no recognized cause can be found.
Objective To determine if testosterone treatment of men 65 years or older with unequivocally …

Behavioral symptoms are a common adverse effect of breast cancer diagnosis and
treatment and include disturbances in energy, sleep, mood, and cognition. These symptoms …

Goals To examine the prevalence of chemotherapy-or radiotherapy-associated side effects
and related treatment burden, and correlates of fatigue and missed work days among cancer …

Fatigue is the most prevalent cancer-related symptom and has a significant adverse impact
on patients' functional ability and quality of life. Hypotheses regarding the aetiology of …

Fatigue is one of the most frequent symptoms in palliative care patients, reported in. 80% of
cancer patients and in up to 99% of patients following radio-or chemotherapy. Fatigue also …

Supportive care plays an increasingly important role in the modern management of multiple
myeloma. While modern treatments have significantly prolonged overall and progression …